Health ❯ Healthcare ❯ Pharmaceuticals ❯ Medications

Weight Loss

UK Regulator Approves Eli Lilly’s Foundayo Tablet for Weight Loss and Type 2 Diabetes

The MHRA’s authorisation allows private prescriptions now, with NHS funding subject to a NICE cost‑effectiveness review.

FDA Clears Lilly’s Foundayo Pill, Escalating GLP-1 Weight-Loss Rivalry

New Study Finds Nearly Fivefold Higher Reported ‘Eye Stroke’ Risk With Wegovy vs Ozempic

Novo Nordisk Launches Wegovy Weight‑Loss Pill in U.S. at $149 Starter Price

FDA Approves Wegovy Weight-Loss Pill as First Oral GLP-1 for Obesity